Brussels, 7 February 2008 - John Wilkinson is the new director general of Eucomed, the European medical technology industry association. Wilkinson takes over the operational leadership from Maurice Wagner who will leave Eucomed at the end of February 2008 to pursue other opportunities after nearly six years of fruitful collaboration.
Wilkinson has over 25 years experience in the medical devices and diagnostics industry. He joins Eucomed from the Association of British Healthcare Industries (ABHI) where he has acted as director general since 1 January 2004. He will begin transition from his current role in March.
When asked about the plans for his new role, Wilkinson says: "I am very much looking forward to working with staff and members on the very strong programme that has been put in place at Eucomed by Maurice Wagner and the board of directors. With the challenges facing our industry it is essential that we work closely with policy makers both on a European and national level to continue to make a positive contribution to the European economy and to provide real benefits for patients."
Eucomed's chairman, Guy Lebeau M.D., comments on Wilkinson's appointment: "The Eucomed board is delighted that John Wilkinson joins the association. We will work closely with Maurice Wagner during the next weeks to ensure a smooth transition toward the new leadership both for our members and our stakeholders in Brussels and the EU member states. We would like to thank Maurice for his contribution and leadership during the past six years."
Key strategic areas for Eucomed in 2008 include shaping the development of tomorrow's healthcare systems, being an active partner with governmental bodies, and demonstrating the clinical benefit, value and cost-effectiveness of medical technology.
Eucomed is the Voice of the medical technology industry in Europe. Eucomed represents directly and indirectly 4500 designers, manufacturers and suppliers of medical technology used in the diagnosis, prevention, treatment and amelioration of disease and disability. Small and medium sized companies make up more than 80% of this sector. The European medical technology industry invests some EUR 3.8 billion in research and development and employs near to 435,000 highly skilled workers. The mission of Eucomed is to improve patient and clinician access to modern, innovative and reliable medical technology.
Mark Grossien
Communications Director
mark.grossien(at)eucomed(dot)be
+32 (0)2.775.92.24
